Skip to Content

GMO Benchmark-Free Allocation III GBMFX

Medalist Rating as of | See GMO Investment Hub
  • NAV / 1-Day Return 26.25  /  0.38 %
  • Total Assets 3.9 Bil
  • Adj. Expense Ratio
    1.160%
  • Expense Ratio 1.160%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Global Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 3.24%
  • Turnover 19%

Morningstar’s Analysis GBMFX

Will GBMFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Devoutly contrarian, for the strong-willed investor.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark Free is a rigorous expression of the firm’s investment approach—contrarian, value-driven, and based on deeply researched seven-year forecasts—but its peculiarity means that an investor requires patience to stick with this offering through periods in which the market environment is dramatically unsympathetic . Also, fees could be lower. All share classes maintain a Morningstar Analyst Rating of Neutral.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GBMFX

  • Current Portfolio Date
  • Equity Holdings 0
  • Bond Holdings 0
  • Other Holdings 9
  • % Assets in Top 10 Holdings 100.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GMO Implementation

87.29
3,623,952,196

GMO Opportunistic Income VI

5.04
209,256,175

GMO Emerging Country Debt VI

4.43
183,782,941

GMO SGM Major Markets VI

2.12
88,168,035

GMO High Yield VI

1.10
45,491,295

State Street Instl Treasury MMkt Invsmt

0.09
3,855,113
Cash and Equivalents

Asset Offset

< 0.01
263,177

Other Liability

−0.07
−2,951,253